In September 2022, the Lancet Global Health Oxygen Commission was announced to recommend ways to ensure that no patient dies for lack of access to medical oxygen
Learn moreIn September 2023, 80 stakeholders came together to accelerate introduction of pneumococcal and rotavirus vaccines in Chad, Guinea, South Sudan, and Somalia
Learn moreIn April 2023, more than 300 stakeholders came together in Spain to commit to better ways to reduce child deaths from pneumonia
Learn moreEvery Breath Counts is a global coalition of over 100 organizations representing the United Nations, global health agencies, non-government agencies, donor foundations, companies, and academic institutions supporting countries to reduce pneumonia deaths from all causes, across all ages. Members work together to help countries close critical gaps in pneumonia prevention, diagnosis, and treatment to save lives now and prepare for the next respiratory pandemic. This will accelerate achievement of the health-related Sustainable Development Goals (SDGs) by 2030 and reduce the risk that another respiratory pandemic will trigger a tragic surge in pneumonia deaths, as COVID-19 did.
Respiratory infections are the worldās biggest infectious killer – claiming 2.2 million lives, including 502,000 children under five, in 2021, according to the latest Global Burden of Disease estimates. Thatās 250 people dying every hour. Yet pneumonia remains a neglected disease and has been called a āglobal cause without championsā – one of the reasons the world was so blindsided by COVID-19, a pandemic of respiratory infection. COVID-19 added 7.9 million additional deaths in 2021, bringing the total number of respiratory infection-related deaths to a massive 10.1 million in that year.
No other infectious condition caused anywhere near this burden of death. Respiratory infection-related deaths even surpassed deaths from heart disease and stroke during the pandemic!
Unless we take action now to reduce pneumonia deaths and the risk of another respiratory pandemic killing more than 10 million people – which experts say is 66% likely in the next 25 years – millions more adults and children will die from pneumonia. It won’t be easy. The global threats of climate change and antimicrobial resistance are increasingly undermining our ability to reduce pneumonia infections and deaths. Climate change increases air pollution, the leading risk factor for pneumonia death, and antibiotic resistant pneumonias are one of the largest contributors to the estimated 1.3 million deaths attributable to antimicrobial resistance that occur each year.
Our cause could not be more urgent. Join us!
Read our Open Letter to the Global Fund Board, as they meet in Malawi from 19 to 22 November, applauding their leadership in increasing access to medical oxygen and making the case for continuing their strong, central role in helping eligible countries close remaining medical oxygen gaps in the countdown to the Sustainable Development Goal 2030 deadline and to prepare for the next pandemic.
Read the Open Letter here!
Vaccinating children and addressing poor nutrition at the same time can save more childrenās lives, because fully-vaccinated, well-nourished children are far less likely to die. This is not a new idea. But it is an idea that isnāt getting the attention and investment needed to make it the new reality for children. Help us change that by watching and sharing “No Vaccination Without Nutrition,” a new campaign from Every Breath Counts in support of Child Survival Action.
Global achievement of the child survival Sustainable Development Goal (SDG) of 25 child deaths for every 1,000 babies born is within reach by 2030 if under-vaccinated populations of children can be protected with the most lifesaving vaccines. A new report, “The Lifesaving Power of Pneumonia and Diarrhea Vaccines for Children,” shows how full coverage of just three vaccines – PCV, rotavirus, and Hib – can prevent hundreds of thousands of child deaths and bring the world much closer to ending preventable child deaths. A new report from Every Breath Counts in support of the Child Survival Action movement.
If you missed the launch of the report on 15 July 2024, you can view the recording and the deck here (English and French), courtesy of the Child Health Taskforce Vaccination Subgroup!
Did you miss our final High Stakes Conversation on Climate Change and Respiratory Health on 12 November to mark World Pneumonia Day and COP29? No problem, you can watch it here!
Did you miss the first two High Stakes Conversations on the lifesaving role of medical oxygen during respiratory pandemics (April) and for SDG achievement (June). Fear not! You can watch the first conversation here and read the summary here, and the second here and here.
Makerere University and others publish a study showing massive increases in access to pulse oximetry (24% to 88%) and medical oxygen (40 to 71%) on the first day more than 60,000 children were admitted to 31 hospitals across Uganda, between 2020 and 2022. More here
Murdoch Children’s Research Institute estimates that current pneumococcal conjugate vaccine (PCV) pricing policies benefit high-income countries and manufacturers who receive 77% of the net economic benefits generated by the vaccine. MoreĀ here
Lancet Respiratory Medicine publishes a Respiratory Syncytial Virus (RSV) series with four major papers and a monumental conclusion: “We are on the cusp of a major effort to combat one of the most widespread and severe infections across all stages of life.”Ā More hereĀ
Every Breath Counts calls on governments to pay close attention to the trial data showing two doses of pneumococcal conjugate vaccine (PCV) are as effective as three or more – with the potential to dramatically reduce the costs of PCV programs. More here
The HAPIN Trial publishes two important papers in the New England Journal of Medicine that question the connection between household air pollution’s impact on both childhood stunting and pneumonia. More here (stunting) and here (pneumonia)
Malaria Consortium and CHAI-led research using the Lives Saved Tool (LiST) estimated that full coverage (>90%) of pulse oximetry and medical oxygen, antibiotics, and vaccines could halve child pneumonia deaths in Ethiopia, Bangladesh, and Chad. More here
University of WashingtonĀ finds 66% of children hospitalized with pneumonia across six Asian and African countries received poor quality care, especially oxygen and antibiotics, with older, sicker children from poor households at greatest risk. More here
Azithromycine pour la Vie des Enfants au Niger – Implementation et Recherche (AVENIR) study results show that mass distribution of azithromycin to Nigerien children aged 1 to 59 months reduced deaths by 14%, replicating the MORDOR trial. More here
It is children and adults exposed to specific factors that are at greatest risk of dying from pneumonia. While the biggest risks for children are malnutrition, air pollution, and low birth weight/preterm birth, adults are more likely to die from pneumonia when exposed to air pollution and smoking, and when they lack access to handwashing facilities. People with multiple illnesses and conditions are also especially vulnerable. Lack of access to vaccination and timely, accurate diagnosis and treatment adds to these risks. Reducing pneumonia means identifying the populations who face the greatest risks and ensuring they are protected first.
Decades of underinvestment in preventing, diagnosing, and treating pneumonia followed by a punishing pandemic has left many countries with health systems that do not have the right equipment, the trained health care workers, and the engineers and technicians to effectively diagnose and treat respiratory infections. At the same time, patients are left to pay for sub-standard care they cannot afford. Many countries across Africa, Asia, and Latin America that are struggling with heavy burdens of pneumonia deaths urgently need more effective strategies to reduce these deaths now, and to prepare for the next respiratory pandemic.
While pneumonia deaths are falling overall (excluding COVID-19), driven by reductions among children, the pace is too slow to achieve the child survival Sustainable Development Goal by 2030. And pneumonia deaths are actually rising among adults, especially those aged over 50 years, driven by the triple threats of air pollution, smoking, and lack of access to handwashing. With climate change increasing the risks of death from infection, air pollution, and heat, with increasing urbanization and aging in many parts of the world, and another respiratory pandemic likely in the next decade, pneumonia is a rising threat that every government must be paying special attention to.
Dear Global Fund Board, The Global Fund must continue its vital work helping eligible countries close the massive gaps in access to medical oxygen that are stymying efforts to achieve the Sustainable Development Goals (SDGs) and prepare for the next pandemic. Oxygen is an essential...
āApart from oxygen, name one other essential medicine that is a topline treatment for all but one of the conditions targeted by the health SDGs?ā This was the focus of the second of three High Stakes Conversations on the role of medical oxygen and global...
For the first time since global child mortality statistics have been collected, the end of child pneumonia deaths is in sight. New estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) show that the number of children dying from pneumonia dropped...
This was the focus of the first of three High Stakes Conversations on the role of medical oxygen and respiratory therapies hosted by Every Breath Counts on 30 April 2024. The event, Respiratory Pandemics and Access to Medical Oxygen, brought together four leading experts on...
Pneumonia is the leading infectious cause of death in children under five and, as a result, the pneumococcal conjugate vaccine, or PCV, is one of the most lifesaving vaccines. However, just six in every ten children are protected with PCV well below the global target...
The A2O2 Resource Library is a platform for all things oxygen - covering every aspect of the oxygen ecosystem from planning to equipment to patient care.